Friend John E. II 4
4 · Cellectar Biosciences, Inc. · Filed Mar 5, 2021
Insider Transaction Report
Form 4
Friend John E. II
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
2021-03-04+330,000→ 330,000 totalExercise: $1.74Exp: 2021-03-04→ Common Stock (330,000 underlying)
Footnotes (1)
- [F1]This option grant is a contingent grant subject to the following conditions: (i) approval by Cellectar's stockholders of shares available under Cellectar's equity incentive plans at Cellectar's 2021 annual meeting of stockholders or other special meeting of stockholders called for such purpose; and (ii) to the extent stockholder approval is received, the grant shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date.